Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Acid, Docosahexaenoic
2. Acids, Docosahexaenoic
3. Acids, Docosahexenoic
4. Docosahexaenoate
5. Docosahexaenoic Acid (all-z Isomer)
6. Docosahexaenoic Acid Dimer (all-z Isomer)
7. Docosahexaenoic Acid, 3,6,9,12,15,18-isomer
8. Docosahexaenoic Acid, 4,7,10,13,16,19-(all-z-isomer)
9. Docosahexaenoic Acid, 4,7,10,13,16,19-(all-z-isomer), Cerium Salt
10. Docosahexaenoic Acid, 4,7,10,13,16,19-(all-z-isomer), Cesium Salt
11. Docosahexaenoic Acid, 4,7,10,13,16,19-(all-z-isomer), Potassium Salt
12. Docosahexaenoic Acid, 4,7,10,13,16,19-(z,z,z,z,z,e-isomer)
13. Docosahexaenoic Acid, 4,7,10,13,16,19-isomer
14. Docosahexaenoic Acid, 4,7,10,13,16,19-isomer, Sodium Salt
15. Docosahexaenoic Acid, Sodium Salt
16. Docosahexaenoic Acids
17. Docosahexenoic Acids
1. Doconexent
2. Cervonic Acid
3. 6217-54-5
4. Cis-4,7,10,13,16,19-docosahexaenoic Acid
5. Docosahexaenoate
6. (4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoic Acid
7. All-cis-dha
8. Doconexento
9. Doconexentum
10. Doxonexent
11. Aquagrow Advantage
12. All-z-docosahexaenoic Acid
13. Doconexent [inn]
14. Martek Dha Hm
15. Ropufa 60
16. All-cis-4,7,10,13,16,19-docosahexaenoic Acid
17. (4z,7z,10z,13z,16z,19z)-docosahexaenoic Acid
18. Docosaheaenoic-acid
19. Docosahexaenoic Acid (all-z)
20. Ccris 7670
21. All-cis-docosa-4,7,10,13,16,19-hexaenoic Acid
22. Zad9okh9jc
23. Docosahexanoic Acid
24. (all-z)-4,7,10,13,16,19-docosahexaenoic Acid
25. Docosa-4,7,10,13,16,19-hexaenoic Acid
26. (4z,7z,10z,13z,16z,19z)-4,7,10,13,16,19-docosahexaenoic Acid
27. Chembl367149
28. Docosahexaenoic Acid(dha)
29. Chebi:28125
30. Delta4,7,10,13,16,19-docosahexaenoic Acid
31. 4-cis,7-cis,10-cis,13-cis,16-cis,19-cis-docosahexaenoic Acid
32. 4z,7z,10z,13z,16z,19z-docosahexaenoic Acid
33. Docosahexaenoic Acid (c22:6 N3)
34. Omega-3 Marine Triglycerides
35. Mfcd00065722
36. 4,7,10,13,16,19-docosahexaenoic Acid, (all-z)-
37. Fa 22:6
38. Efalex
39. Ncgc00161345-04
40. C22:6 (n-3)
41. Docosahexaenoic Acid (22:6 N-3)
42. 22:6 N-3
43. 22:6(n-3)
44. Cis-4,7,10,13,16,19-docosahexanoic Acid
45. 4,7,10,13,16,19-docosahexaenoic Acid
46. C22:6n-3,6,9,12,15,18
47. Monolife 50
48. Marinol D 50tg
49. Sr-05000002130
50. Unii-zad9okh9jc
51. Doconexentum [inn-latin]
52. Doconexento [inn-spanish]
53. Dha-[21,21,22,22,22-d5]
54. Cervonate
55. Dtxsid5040465
56. 1fdq
57. Algal Dha
58. Docohexanenoic Acid
59. Docosahexanenoic Acid
60. Omega 3 Fatty Acid
61. All-z-docosahexaenoate
62. Spectrum5_002062
63. Docosahexaenoic Acid (6ci)
64. Dsstox_cid_20465
65. Dsstox_rid_79498
66. Dsstox_gsid_40465
67. Schembl19577
68. Bspbio_001298
69. Docoshexaenoic Acid (powder)
70. Mls004773950
71. Bml3-b02
72. Gtpl1051
73. Retriacyl (proposed Trade Name)
74. Bcbcmap01_000145
75. Docosahexaenoic Acid [mi]
76. Hms1361a20
77. Hms1791a20
78. Hms1989a20
79. Hms3402a20
80. Hms3649j15
81. Docosahexaenoic Acid [inci]
82. Hy-b2167
83. Zinc4474564
84. Docosahexaenoic Acid [vandf]
85. Tox21_111992
86. Bdbm50210259
87. Docosahexaenoic Acid [mart.]
88. Lmfa01030185
89. Docosahexaenoic Acid [usp-rs]
90. Docosahexaenoic Acid [who-dd]
91. Akos015962159
92. Ac-1010
93. Ccg-207958
94. Ccg-208135
95. Cs-6261
96. Db03756
97. Kl-0761
98. Idi1_033768
99. 4,7,10,13,16,19-docosahexaenoate
100. Ncgc00161345-01
101. Ncgc00161345-02
102. Ncgc00161345-03
103. Ncgc00161345-05
104. Ncgc00161345-07
105. All Cis- Docosahexaenoic Acid (cis-dha)
106. Smr001881493
107. Cas-6217-54-5
108. Cis-4,7,10,13,16,19-docosahexanoate
109. D2226
110. S6454
111. C06429
112. H10987
113. Ab01563379_01
114. Docosahexaenoic Acid (dha) (c22:6 N3)
115. Docosahexaenoic Acid-rich Single Cell Oil
116. 217d545
117. Q423345
118. Sr-05000002130-1
119. Sr-05000002130-4
120. Brd-k39965020-001-02-6
121. 4,7,10,13,16,19-docosahexaenoic Acid, (all Cis)-
122. A320050000
123. Cis-4,7,10,13,16,19-docosahexaenoic Acid, >=98%
124. Fa(22:6(4z,7z,10z,13z,16z,19z))
125. Z,z,z,z,z,z-docosa-4,7,10,13,16,19-hexaenoic Acid
126. (all-z)-4,7,10,13,16,19-docosahexaenoic Acid, Dha
127. 800e8e72-bbf4-46f7-a60b-b8f2b54669c7
128. C22h32o2 (cis-4,7,10,13,16,19-docosahexaenoic Acid)
129. 4,7,10,13,16,19-docosahexaenoic Acid, (all-z)- (8ci)
130. Cis-4,7,10,13,16,19-docosahexaenoic Acid, Analytical Standard
131. Docosa-4z,7z,10z,13z,16z,19z-hexaenoic Acid (22:6, N-3)
132. (4z,7z,10z,13z,16z, 19z)-docosa-4,7,10,13,16,19-hexaenoic Acid
133. (4z,7z,10z,13z,16z,19z)-docosa-4, 7,10,13,16,19-hexaenoic Acid
134. (4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19- Hexaenoic Acid
135. Cis-4,7,13,16,19-docosahexaenoic Acid (stabilized With Vitamine E)
136. 4,7,10,13,16,19-docosahexaenoic Acid, (4z,7z,10z,13z,16z,19z)- (9ci)
137. Docosahexaenoic Acid (dha) (c22:6) (constituent Of Krill Oil) [dsc]
138. 1024594-51-1
139. Cis-4,7,10,13,16,19-docosahexaenoic Acid, 500 Mug/ml In Ethanol, Certified Reference Material
| Molecular Weight | 328.5 g/mol |
|---|---|
| Molecular Formula | C22H32O2 |
| XLogP3 | 6.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 14 |
| Exact Mass | 328.240230259 g/mol |
| Monoisotopic Mass | 328.240230259 g/mol |
| Topological Polar Surface Area | 37.3 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 462 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 6 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Used as a high-docosahexaenoic acid (DHA) oral supplement.
Treatment of Retinitis Pigmentosa
DHA in the central nervous system is found in the phospholipid bilayers where it modulates the physical environment and increase the free volume within the membrane bilayer. It influences the G-protein coupled receptor activity and affects transmembrane transport and cell interaction with the exterior world. It is also reported to promote apoptosis, neuronal differentiation and ion channel activity. Like other polyunsaturated fatty acids, DHA acts as a ligand at PPARs that plays an anti-inflammatory effect and regulate inflammatory gene expression and NFB activation. DHA also gives rise to resolvins and related compounds (e.g., protectins) through pathways involving cyclooxygenase and lipoxygenase enzymes to resolve the inflammatory responses.
Absorption
Like other omega-3 fatty acids, DHA is hydrolyzed from the intestines and delivered through the lymphatic circulation. Plasma DHA concentrations increase in a dose-dependent and saturable manner.
Volume of Distribution
DHA is the most abundant n3 fatty acid in membranes and is present in all organs. It is also the most variable among organs and is particularly abundant in neural tissue, such as brain and retina, where it is several hundred-fold more abundant than EPA.
DHA can be metabolized into DHA-derived specialized pro-resolving mediators (SPMs), DHA epoxides, electrophilic oxo-derivatives (EFOX) of DHA, neuroprostanes, ethanolamines, acylglycerols, docosahexaenoyl amides of amino acids or neurotransmitters, and branched DHA esters of hydroxy fatty acids, among others. It is converted to 17-hydroperoxy-DHA derivatives via COX-2 and 15-LOX and 5-LOX activity. These derivatives are further converted into D-series resolvins and protectins with potent anti-inflammatory potential and potent neuroprotective effect. DHA may also be metabolized to 19,20-epoxydocosapentaenoic acids (EDPs) and isomers via CYP2C9 activity. Epoxy metabolites are reported to mediate anti-tumor activity by inhibiting angiogenesis, tumor growth, and metastasis.
Approximately 20 hours.
DHA and its conversion to other lipid signalling moleccules compete with the arachidonic acid cascade from endogenous phospholipids and shift the inflammatory state to being more anti-inflammatory. DHA inhibits endotoxin-stimulated production of IL-6 and IL-8 in human endothelial cells. Derivatives of DHA are anti-inflammatory lipid mediators. Lipid mediators resolvin D1 and protectin D1 all inhibit transendothelial migration of neutrophils, so preventing neutrophilic infiltration at sites of inflammation, resolvin D1 inhibits IL-1 production, and protectin D1 inhibits TNF and IL-1 production. Monoxydroxy derivative of DHA converted by LOX inhibit thromboxane-induced platelet aggregation. DHA supplementation has also shown to reduce the levels of serum C-reactive protein (CRP) and other circulating markers of inflammation such as neutrophils in hypertriglyceridemic men. DHA acts as a ligand at peroxisome proliferator-activated receptor (PPAR) gamma and alpha that regulate lipid signalling molecule-mediated transduction pathways and modulate inflammation. As a natural ligand, DHA induces a protective effect in retinal tissues by activating retinoid x receptors and subsequent ERK/MAPK signaling pathway in photoreceptors to promote their survival and differentiation, stimulating the expression of antiapoptotic proteins such as Bcl-2 and preserving mitochondrial membrane potential.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29567
Submission : 2015-07-20
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41358
Submission : 2025-04-30
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23126
Submission : 2009-10-06
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22078
Submission : 2008-10-09
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28425
Submission : 2014-06-16
Status : Inactive
Type : II




FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29567
Submission : 2015-07-20
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23126
Submission : 2009-10-06
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41358
Submission : 2025-04-30
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22078
Submission : 2008-10-09
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28425
Submission : 2014-06-16
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Registrant Name : B. Braun Korea Co., Ltd.
Registration Date : 2025-04-14
Registration Number : 20250414-210-J-1854
Manufacturer Name : Croda Europe Ltd
Manufacturer Address : Barnfield Road, Leek, Staffordshire, ST13 5QJ, England

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Symbiotec, a leading API manufacturing company based in Indore, Central India, specializes in Cortico-Steroids and Steroid-Hormone APIs. Since 1995, their focus on R&D, sustainable...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : Bioplus Life Sciences is a leading provider of contract research, development, distribution and manufacturing services for licensed and OTC (nutritional) pharmaceuticals. With a gl...

About the Company : Ennature Biopharma marketing division of USD 700 million India Glycols Limited is surging ahead as a leading manufacturer of Thiocolchicoside an active muscle relaxant & Colchicine...

About the Company : Royal DSM, founded in 1902, is a global, purpose-led health, nutrition, and bioscience company that specializes in human and animal health and nutrition solutions. Its primary goal...

About the Company : Sajjala Bio Labs is a two year old bio pharmaceutical API production company headquartered in Hyderabad. At the moment, we commercially produce and sell Enoxaparin Sodium and L-asp...

About the Company : Zenfold Sustainable Technologies (ZST) is a specialty and fine chemicals company, established in 2021. Our advanced technological capabilities and state-of-the-art infrastructure a...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Eicosapentaenoic Acid|Docosahexaenoic Acid is a Dietary Supplement drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Frail Elderly Syndrome.
Lead Product(s): Eicosapentaenoic Acid|Docosahexaenoic Acid,DHA
Therapeutic Area: Genetic Disease Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 19, 2025

Lead Product(s) : Eicosapentaenoic Acid|Docosahexaenoic Acid,DHA
Therapeutic Area : Genetic Disease
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of a Combined Exercise and Anti-Inflammatory Nutritional Intervention in Frail Older Adults
Details : Eicosapentaenoic Acid|Docosahexaenoic Acid is a Dietary Supplement drug candidate, which is currently being evaluated in Undisclosed clinical studies for the treatment of Frail Elderly Syndrome.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
September 19, 2025

Details:
Docosahexaenoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition Disorders.
Lead Product(s): DHA,Arachidonic Acid
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 01, 2024

Lead Product(s) : DHA,Arachidonic Acid
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Docosahexaenoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognition Disorders.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 01, 2024

Details:
Docosahexaenoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): DHA,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Unity Health Toronto
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 05, 2024

Lead Product(s) : DHA,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Unity Health Toronto
Deal Size : Inapplicable
Deal Type : Inapplicable
A Dose Response Investigation of Docosahexaenoic Acid (DHA)
Details : Docosahexaenoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 05, 2024

Details:
Mixture Of Extracts is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognitive Dysfunction.
Lead Product(s): Mixture Of Extracts,DHA
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Plant Extract/Herbal
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 12, 2024

Lead Product(s) : Mixture Of Extracts,DHA
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Consuming a Mixture of Extracts and DHA on the Mild Cognitive Impairment
Details : Mixture Of Extracts is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Cognitive Dysfunction.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 12, 2024

Details:
DHA is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Infant Nutrition Disorders.
Lead Product(s): DHA,Inapplicable
Therapeutic Area: Nutrition and Weight Loss Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Mead Johnson Nutrition
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable January 16, 2024

Lead Product(s) : DHA,Inapplicable
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Mead Johnson Nutrition
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : DHA is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Infant Nutrition Disorders.
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
January 16, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Pentec will receive the exclusive rights to distribute Altemia (docosahexaenoic acid ethyl ester), a proprietary oral formulation of emulsified docohexanoic acid, clinically evaluated to restore DHA levels and help reduce inflammation associated with SCD, in the United States.
Lead Product(s): DHA,Inapplicable
Therapeutic Area: Genetic Disease Brand Name: Altemia
Study Phase: Approved FDFProduct Type: Dietary Supplement
Sponsor: Pentec Health
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement May 17, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : DHA,Inapplicable
Therapeutic Area : Genetic Disease
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Pentec Health
Deal Size : Undisclosed
Deal Type : Agreement
Details : Pentec will receive the exclusive rights to distribute Altemia (docosahexaenoic acid ethyl ester), a proprietary oral formulation of emulsified docohexanoic acid, clinically evaluated to restore DHA levels and help reduce inflammation associated with SCD...
Product Name : Altemia
Product Type : Dietary Supplement
Upfront Cash : Undisclosed
May 17, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Aptamil (Iron) First Infant Milk Stage 1(This infant formula is appropriate for most infants and meets U.S. nutrient requirements, but it may not be suitable for infants born prematurely, or with a low birth weight.
Therapeutic Area: Hematology Brand Name: Aptamil
Study Phase: Approved FDFProduct Type: Vitamins/Minerals/Inorganic Salts
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 17, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Therapeutic Area : Hematology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Infant Formula Update: June 17, 2022
Details : Aptamil (Iron) First Infant Milk Stage 1(This infant formula is appropriate for most infants and meets U.S. nutrient requirements, but it may not be suitable for infants born prematurely, or with a low birth weight.
Product Name : Aptamil
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
June 17, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Eicosapentaenoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of COVID-19.
Lead Product(s): Icosapent Ethyl,DHA
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 16, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Icosapent Ethyl,DHA
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Eicosapentaenoic Acid is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 16, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The partnership will see Catalent use its proprietary OptiGel® DR technology to encapsulate OmeGo (docosahexaenoic acid), HBC’s unique fish oil derived from sustainable, traceable, and fresh Norwegian Atlantic salmon.
Lead Product(s): DHA,Icosapent Ethyl
Therapeutic Area: Immunology Brand Name: OmeGo
Study Phase: UndisclosedProduct Type: Dietary Supplement
Sponsor: Hofseth BioCare
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership May 12, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : DHA,Icosapent Ethyl
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Hofseth BioCare
Deal Size : Undisclosed
Deal Type : Partnership
Details : The partnership will see Catalent use its proprietary OptiGel® DR technology to encapsulate OmeGo (docosahexaenoic acid), HBC’s unique fish oil derived from sustainable, traceable, and fresh Norwegian Atlantic salmon.
Product Name : OmeGo
Product Type : Dietary Supplement
Upfront Cash : Undisclosed
May 12, 2021

Details:
Université de Sherbrooke in Canada will test if LYSOVETA, Aker BioMarine’s new delivery platform based on LPC-bound EPA/DHA from krill, is more effective in increasing the concentration of DHA in the brain and improving cognition.
Lead Product(s): Icosapent Ethyl,DHA
Therapeutic Area: Neurology Brand Name: Lysoveta
Study Phase: PreclinicalProduct Type: Miscellaneous
Sponsor: Aker BioMarine
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration February 15, 2021

Lead Product(s) : Icosapent Ethyl,DHA
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Aker BioMarine
Deal Size : Undisclosed
Deal Type : Collaboration
Aker BioMarine Enters Into Research Collaboration for Alzheimer’s
Details : Université de Sherbrooke in Canada will test if LYSOVETA, Aker BioMarine’s new delivery platform based on LPC-bound EPA/DHA from krill, is more effective in increasing the concentration of DHA in the brain and improving cognition.
Product Name : Lysoveta
Product Type : Miscellaneous
Upfront Cash : Undisclosed
February 15, 2021

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral
Dosage Form : Tablet
Grade : Oral
Application : Emulsifying Agents
Excipient Details : HDK N20 Pharma is used as a pharmaceutical emulsifying agent in tablets, capsules, syrups, and solutions.
Dosage Form : Suspension
Grade : Oral, Topical
Application : Rheology Modifiers
Excipient Details : HPMC 60HD4000 is used as thickener and viscosity modifier in oral solid, liquid and topical dosage forms.
Dosage Form : Suspension
Grade : Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Suspension
Grade : Topical
Application : Rheology Modifiers
Excipient Details : Silfoam® SE 2 is used as a thickener and a viscosity modifier in liquid and topical dosage forms.
Dosage Form : Capsule
Grade : Oral
Application : Thickeners and Stabilizers
Excipient Details : Sterotex K is used as a pharmaceutical stabilizer in capsules filled with liquid and tablets.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Dosage Form : Cream / Lotion / Ointment
Grade : Topical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral & Topical
Application : Controlled & Modified Release
Excipient Details : Talc is a widely used as a dissolution retardant in the development of controlled release products. Talc is also used as a lubricant in tablet formulations.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Orodispersible Tablet
Grade : Not Available
Application : Chewable & Orodispersible Aids
Excipient Details : Orally Disintegrating Tablets
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Enteric Coatings
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Enteric Coatings
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Dosage Form : Tablet
Grade : Not Available
Brand Name : SheffCoat™ TF Plus
Application : Coating Systems & Additives
Excipient Details : Titanium Oxide Free Coatings
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Dosage Form : Cream / Lotion / Ointment, Emulsion, Gel, Solution, Tablet
Grade : Topical, Oral
Category : API Stability Enhancers, Emulsifying Agents, Fillers, Diluents & Binders
Application : Fillers, Diluents & Binders, Taste Masking
Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.
Dosage Form : Capsule, Granule / Pellet, Tablet, Injectable / Parenteral
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Thickeners and Stabilizers
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.
Dosage Form : Injectable / Parenteral, Tablet
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers
Application : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers
Excipient Details : D-Mannitol protects proteins from denaturation & degradation. It is used as a stabilizer in liquid products including biologic injectables & vaccines.
Pharmacopoeia Ref : USP, EP, BP, JP, ChP
Technical Specs : Low Endotoxin, Low Metals
Ingredient(s) : Mannitol
Dosage Form : Granule / Pellet, Tablet
Grade : Oral
Category : Fillers, Diluents & Binders, Granulation, Solubilizers
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Coating Systems & Additives, Fillers, Diluents & Binders
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
15
PharmaCompass offers a list of DHA API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right DHA manufacturer or DHA supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred DHA manufacturer or DHA supplier.
PharmaCompass also assists you with knowing the DHA API Price utilized in the formulation of products. DHA API Price is not always fixed or binding as the DHA Price is obtained through a variety of data sources. The DHA Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DHA manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DHA, including repackagers and relabelers. The FDA regulates DHA manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DHA API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DHA manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DHA supplier is an individual or a company that provides DHA active pharmaceutical ingredient (API) or DHA finished formulations upon request. The DHA suppliers may include DHA API manufacturers, exporters, distributors and traders.
click here to find a list of DHA suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DHA DMF (Drug Master File) is a document detailing the whole manufacturing process of DHA active pharmaceutical ingredient (API) in detail. Different forms of DHA DMFs exist exist since differing nations have different regulations, such as DHA USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A DHA DMF submitted to regulatory agencies in the US is known as a USDMF. DHA USDMF includes data on DHA's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DHA USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of DHA suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DHA Drug Master File in Korea (DHA KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DHA. The MFDS reviews the DHA KDMF as part of the drug registration process and uses the information provided in the DHA KDMF to evaluate the safety and efficacy of the drug.
After submitting a DHA KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DHA API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DHA suppliers with KDMF on PharmaCompass.
DHA Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DHA GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DHA GMP manufacturer or DHA GMP API supplier for your needs.
A DHA CoA (Certificate of Analysis) is a formal document that attests to DHA's compliance with DHA specifications and serves as a tool for batch-level quality control.
DHA CoA mostly includes findings from lab analyses of a specific batch. For each DHA CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DHA may be tested according to a variety of international standards, such as European Pharmacopoeia (DHA EP), DHA JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DHA USP).
Contact Us!